Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein

Doğaner, Adem; ALKAN BAYLAN, FİLİZ; KIRISCI, MEHMET; Altıntaş Aykan, Duygun; Koçarslan, Aydemir; Orak, Yavuz

doi:10.3906/sag-2002-53

Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein

Mehmet KİRİŞCİ, (Kahramanmaraş Sütçü İmam Üniversitesi, Tıp Fakültesi, Kalp Damar Cerrahisi Anabilim Dalı, Kahramanmaraş, Türkiye)

Aydemir KOÇARSLAN, (Kahramanmaraş Sütçü İmam Üniversitesi, Tıp Fakültesi, Kalp Damar Cerrahisi Anabilim Dalı, Kahramanmaraş, Türkiye)

Duygun ALTINTAŞ AYKAN, (Kahramanmaraş Sütçü İmam Üniversitesi, Tıp Fakültesi, Farmakoloji Anabilim Dalı, Kahramanmaraş, Türkiye)

Filiz BAYLAN, (Kahramanmaraş Sütçü İmam Üniversitesi, Tıp Fakültesi, Biyokimya Anabilim Dalı, Kahramanmaraş, Türkiye)

Adem DOĞANER, (Kahramanmaraş Sütçü İmam Üniversitesi, Tıp Fakültesi, Biyoistatistik Anabilim Dalı, Kahramanmaraş, Türkiye)

Yavuz ORAK (Kahramanmaraş Sütçü İmam Üniversitesi, Tıp Fakültesi, Anesteziyoloji ve Reanimasyon Anabilim Dalı, Kahramanmaraş, Türkiye)

Turkish Journal of Medical Sciences

0 0

Yıl: 2020 Cilt: 50 Sayı: 4 Sayfa Aralığı: 999 - 1006 Metin Dili: İngilizce DOI: 10.3906/sag-2002-53 İndeks Tarihi: 31-08-2020

Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein

Öz:

Background/aim: Our aim in this study was to compare the efficacy and safety of crystalloid del Nido solution and cold bloodcardioplegia solution on clinical and laboratory parameters.Materials and methods: Sixty patients who underwent elective coronary bypass operation between July 2019 and January 2020 wereincluded in our study. Patients were divided into 2 groups of 30 patients using del Nido solution (DNS) and cold blood cardioplegiasolution (CBCS), which were given for cardiac arrest. Demographic data, preoperative, postoperative 0th h, 6th h and 4th day creatinekinase myocardial band (CK-MB) and troponin I values were compared with a specific cardiac enzyme heart-type fatty acid-bindingprotein (H-FABP).Results: We found that aortic cross clamp duration and cardiopulmonary bypass (CPB) time were shorter in patients using del Nidosolution than cold blood cardioplegia solution (57.30 ± 23.57 min, 76.07 ± 27.18 min, P = 0.006) (95.07 ± 23.06 min, 114.13 ± 33.93, P =0.014). Total cardioplegia solution volume was higher in the cold blood cardioplegia solution group (1426.67 ± 416.00 vs. 1200 ± 310.73P = 0.02). Preoperative and postoperative levels of cardiac enzymes including CK-MB, troponin I and H-FABP were comparable in delNido solution and cold blood cardioplegia solution groups.Conclusion: According to these results, when we compare both demographic data and CK-MB, troponin I and H-FABP levels, bothcardioplegia solutions were comparable regarding safety and efficacy in terms of myocardial protection.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Roe BB, Hutchinson JC, Fishman NH, Ullyot DJ, Smith DL. Myocardial protection with cold, ischemic, potassium-induced cardioplegia. The Journal of Thoracic and Cardiovascular Surgery 1977; 73 (3): 366-374.
2. Conti VR, Bertranou EG, Blackstone EH, Kirklin JW, Digerness SB. Cold cardioplegia versus hypothermia for myocardial protection. Randomized clinical study. The Journal of Thoracic and Cardiovascular Surgery 1978; 76 (5): 577-589.
3. Melrose DG, Dreyer B, Bentall HH, Baker JB. Elective cardiac arrest. Lancet 1955; 269: 21-22. doi: 10.1016/S0140- 6736(55)93381-X
4. Matte GS, Del Nido PJ. History and use of del Nido cardioplegia solution at Boston Children’s Hospital. The Journal of ExtraCorporeal Technology 2012; 44: 98-103.
5. Bojan M, Peperstraete H, Lilot M, Tourneur L, Vouhé P et al. Cold histidine-tryptophan-ketoglutarate solution and repeated oxygenated warm blood cardioplegia in neonates with arterial switch operation. The Annals of Thoracic Surgery 2013; 95 (4): 1390-1396. doi: 10.1016/j.athoracsur.2012.12.025
6. Yerebakan H, Sorabella RA, Najjar M, Castillero E, Mongero L et al. Del Nido cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison. Journal of Cardiothoracic Surgery 2014; 9: 141. doi: 10.1186/ s13019-014-0141-5
7. Timek T, Willekes C, Hulme O, Himelhoch B, Nadeau D et al. Propensity matched analysis of del Nido cardioplegia in adult coronary artery bypass grafting: initial experience with 100 consecutive patients. The Annals of Thoracic Surgery 2016; 101 (6): 2237-2241. doi: 10.1016/j.athoracsur.2015.12.058
8. Smigla G, Jaquiss R, Walczak R, Bonadonna D, Kaemmer D et al. Assessing the safety of del Nido cardioplegia solution in adult congenital cases. Perfusion 2014; 29 (6): 554-558. doi: 10.1177/0267659114543346
9. Ota T, Yerebakan H, Neely RC, Mongero L, George I et al. Short-term outcomes in adult cardiac surgery in the use of del Nido cardioplegia solution. Perfusion 2016; 31 (1): 27-33. doi: 10.1177/0267659115599453
10. Mick SL, Robich MP, Houghtaling PL, Gillinov AM, Soltesz EG et al. Del Nido versus Buckberg cardioplegia in adult isolated valve surgery. The Journal of Thoracic and Cardiovascular Surgery 2015; 149 (2): 626-636.e5. doi: 10.1016/j. jtcvs.2014.10.085
11. Guajardo Salinas GE, Nutt R, Rodriguez-Araujo G. Del Nido cardioplegia in low risk adults undergoing first time coronary artery bypass surgery. Perfusion 2017; 32 (1): 68-73. doi: 10.1177/0267659116661051
12. Kragten JA, Van Nieuwenhoven FA, Van Dieijen-Visser MP, Theunissen PH, Hermens WT et al. Distribution of myoglobin and fatty acid-binding protein in human cardiac autopsies. Clinical Chemistry 1996; 42 (2): 337-338.
13. Storch J, Thumser AE. The fatty acid transport function of fatty acid-binding proteins. Biochimica et Biophysica Acta (BBA) 2000; 1486 (1): 28-44.
14. Glatz JF, Storch J. Unravelling the significance of cellular fatty acid-binding proteins. Current Opinion in Lipidology 2001; 12 (3): 267-274.
15. Fransen EJ, Maessen JG, Hermens WT, Glatz JF. Demonstration of ischemia-reperfusion injury separate from postoperative infarction in coronary artery bypass graft patients. The Annals of Thoracic Surgery 1998; 65 (1): 48-53.
16. Kim Y, Kim H, Kim SY, Lee HK, Kwon HJ et al. Automated heart-type fatty acid-binding protein assay for the early diagnosis of acute myocardial infarction. American Journal of Clinical Pathology 2010; 134 (1): 157-162. doi: 10.1309/ AJCP0F6AXRCJMQQG
17. Kabekkodu SP, Mananje SR, Saya RP. A study on the role of heart type fatty acid binding protein in the diagnosis of acute myocardial infarction. Journal of Clinical and Diagnostic Research 2016; 10 (1): OC07-OC10. doi: 10.7860/ JCDR/2016/15713.7057
18. Agewall S, Giannitsis E. “Troponin elevation in coronary ischemia and necrosis”. Current Atherosclerosis Reports 2014; 16 (3): 396. doi: 10.1007/s11883-013-0396-7
19. Vupputuri A, Sekhar S, Krishnan S, Venugopal K, Natarajan KU. Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain. Indian Heart Journal 2015; 67 (6): 538-542. doi: 10.1016/j. ihj.2015.06.035
20. Azzazy HM, Pelsers MM, Christenson RH. Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications. Clinical Chemistry 2006; 52 (1): 19-29.
21. Tambara K, Fujita M, Miyamoto S, Doi K, Nishimura K et al. Pericardial fluid level of heart-type cytoplasmic fatty acidbinding protein (H-FABP) is an indicator of severe myocardial ischemia. International Journal of Cardiology 2004; 93 (2-3): 281-284.
22. Kim JS, Jeong JH, Moon SJ, Ahn H, Hwang HY. Sufficient myocardial protection of del Nido cardioplegia regardless of ventricular mass and myocardial ischemic time in adult cardiac surgical patients. Journal of Thoracic Disease 2016; 8 (8): 2004- 2010. doi: 10.21037/jtd.2016.06.66
23. Timek T, Willekes C, Hulme O, Himelhoch B, Nadeau D et al. Propensity matched analysis of del Nido cardioplegia in adult coronary artery bypass grafting: initial experience with 100 consecutive patients. The Annals of Thoracic Surgery 2016; 101 (6): 2237-2241. doi: 10.1016/j.athoracsur.2015.12.058
24. Ucak HA, Uncu H. Comparison of del Nido and intermittent warm blood cardioplegia in coronary artery bypass grafting surgery. Annals of Thoracic and Cardiovascular Surgery 2019; 25 (1): 39-45. doi: 10.5761/atcs.oa.18-00087
25. Guru V, Omura J, Alghamdi AA, Weisel R, Fremes SE. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation 2006; 114 (1 Suppl): I331-I338.
26. Sá MP, Rueda FG, Ferraz PE, Chalegre ST, Vasconcelos FP et al. Is there any difference between blood and crystalloid cardioplegia for myocardial protection during cardiac surgery? A metaanalysis of 5576 patients from 36 randomized trials. Perfusion 2012; 27 (6): 535-546. doi: 10.1177/0267659112453754
27. Cubero-Gallego H, Lorenzo M, Heredia M, Gómez I, Tamayo E. Diagnosis of perioperative myocardial infarction after heart valve surgery with new cut-off point of high-sensitivity troponin T and new electrocardiogram or echocardiogram changes. The Journal of Thoracic and Cardiovascular Surgery 2017; 154 (3): 895-903. doi: 10.1016/j.jtcvs.2017.02.013
28. De Jonge M, Van Boxtel AG, Soliman Hamad MA, Mokhles MM, Bramer S et al. Intermittent warm blood versus cold crystalloid cardioplegia for myocardial protection: a propensity scorematched analysis of 12-year single-center experience. Perfusion 2015; 30 (3): 243-249. doi: 10.1177/0267659114540023
29. Li Y, Lin H, Zhao Y, Li Z, Liu D et al. Del Nido cardioplegia for myocardial protection in adult cardiac surgery: a systematic review and meta-analysis. ASAIO Journal 2018; 64 (3): 360- 367. doi: 10.1097/MAT.0000000000000652
30. Liebetrau C, Nef HM, Dörr O, Gaede L, Hoffmann J et al. Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction. Heart 2014; 100 (8): 652- 657. doi: 10.1136/heartjnl-2013-305253
31. Fischer TA, McNeil PL, Khakee R, Finn P, Kelly RA et al. Cardiac myocyte membrane wounding in the abruptly pressureoverloaded rat heart under high wall stress. Hypertension 1997; 30 (5): 1041-1046.
32. Iida M, Yamazaki M, Honjo H, Kodama I, Kamiya K. Predictive value of heart-type fatty acid-binding protein for left ventricular remodelling and clinical outcome of hypertensive patients with mild-to-moderate aortic valve diseases. Journal of Human Hypertension 2007; 21 (7): 551-557.
33. Binas B, Erol E. FABPs as determinants of myocellular and hepatic fuel metabolism. Molecular and Cellular Biochemistry 2007; 299 (1-2): 75-84.
34. Tang MK, Kindler PM, Cai DQ, Chow PH, Li M et al. Hearttype fatty acid binding proteins are upregulated during terminal differentiation of mouse cardiomyocytes, as revealed by proteomic analysis. Cell and Tissue Research 2004; 316 (3): 339-347.
35. Wang S, Zhou Y, Andreyev O, Hoyt RF Jr, Singh A et al. Overexpression of FABP3 inhibits human bone marrow derived mesenchymal stem cell proliferation but enhances their survival in hypoxia. Experimental Cell Research 2014; 323 (1): 56-65. doi: 10.1016/j.yexcr.2014.02.015
36. Zhu C, Hu DL, Liu YQ, Zhang QJ, Chen FK et al. Fabp3 inhibits proliferation and promotes apoptosis of embryonic myocardial cells. Cell Biochemistry and Biophysics 2011; 60 (3): 259-266. doi: 10.1007/s12013-010-9148-2
37. Zhuang L, Li C, Chen Q, Jin Q, Wu L et al. Fatty acid-binding protein 3 contributes to ischemic heart injury by regulating cardiac myocyte apoptosis and MAPK pathways. The American Journal of Physiology-Heart and Circulatory Physiology 2019; 316 (5): H971-H984. doi: 10.1152/ajpheart.00360.2018
38. Ye XD, He Y, Wang S, Wong GT, Irwin MG et al. Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis. Acta Pharmacologica Sinica 2018; 39 (7): 1155-1163. doi: 10.1038/aps.2018.37
39. Kleine AH, Glatz JF, Van Nieuwenhoven FA, Van der Vusse GJ. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Molecular and Cellular Biochemistry 1992; 116 (1-2): 155-162.
40. Van Nieuwenhoven FA, Kleine AH, Wodzig WH, Hermens WT, Kragten HA et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995; 92 (10): 2848-2854.
41. Suzuki K, Sawa Y, Kadoba K, Takahashi T, Ichikawa H et al. Early detection of cardiac damage with heart fatty acid-binding protein after cardiac operations. The Annals of Thoracic Surgery 1998; 65 (1): 54-58.
42. Petzold T, Feindt P, Sunderdiek U, Boeken U, Fischer Y et al. Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. The European Journal of Cardio-Thoracic Surgery 2001; 19 (6): 859-864.
43. Malik V, Kale SC, Chowdhury UK, Ramakrishnan L, Chauhan S et al. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring hearttype fatty-acid-binding protein release. Texas Heart Institute Journal 2006; 33 (3): 321-327.
44. Thielmann M, Pasa S, Holst T, Wendt D, Dohle DS et al. Hearttype fatty acid binding protein and ischemia-modified albumin for detection of myocardial infarction after coronary artery bypass graft surgery. The Annals of Thoracic Surgery 2017; 104 (1): 130-137. doi: 10.1016/j.athoracsur.2016.10.051
45. Jo MS, Lee J, Kim SY, Kwon HJ, Lee HK et al. Comparison between creatine kinase MB, heart-type fatty acid-binding protein, and cardiac troponin T for detecting myocardial ischemic injury after cardiac surgery. Clinica Chimica Acta 2019; 488: 174-178. doi: 10.1016/j.cca.2018.10.040

APA	KIRISCI M, Koçarslan A, Altıntaş Aykan D, ALKAN BAYLAN F, Doğaner A, Orak Y (2020). Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein. , 999 - 1006. 10.3906/sag-2002-53
Chicago	KIRISCI MEHMET,Koçarslan Aydemir,Altıntaş Aykan Duygun,ALKAN BAYLAN FİLİZ,Doğaner Adem,Orak Yavuz Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein. (2020): 999 - 1006. 10.3906/sag-2002-53
MLA	KIRISCI MEHMET,Koçarslan Aydemir,Altıntaş Aykan Duygun,ALKAN BAYLAN FİLİZ,Doğaner Adem,Orak Yavuz Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein. , 2020, ss.999 - 1006. 10.3906/sag-2002-53
AMA	KIRISCI M,Koçarslan A,Altıntaş Aykan D,ALKAN BAYLAN F,Doğaner A,Orak Y Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein. . 2020; 999 - 1006. 10.3906/sag-2002-53
Vancouver	KIRISCI M,Koçarslan A,Altıntaş Aykan D,ALKAN BAYLAN F,Doğaner A,Orak Y Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein. . 2020; 999 - 1006. 10.3906/sag-2002-53
IEEE	KIRISCI M,Koçarslan A,Altıntaş Aykan D,ALKAN BAYLAN F,Doğaner A,Orak Y "Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein." , ss.999 - 1006, 2020. 10.3906/sag-2002-53
ISNAD	KIRISCI, MEHMET vd. "Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein". (2020), 999-1006. https://doi.org/10.3906/sag-2002-53

APA	KIRISCI M, Koçarslan A, Altıntaş Aykan D, ALKAN BAYLAN F, Doğaner A, Orak Y (2020). Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein. Turkish Journal of Medical Sciences, 50(4), 999 - 1006. 10.3906/sag-2002-53
Chicago	KIRISCI MEHMET,Koçarslan Aydemir,Altıntaş Aykan Duygun,ALKAN BAYLAN FİLİZ,Doğaner Adem,Orak Yavuz Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein. Turkish Journal of Medical Sciences 50, no.4 (2020): 999 - 1006. 10.3906/sag-2002-53
MLA	KIRISCI MEHMET,Koçarslan Aydemir,Altıntaş Aykan Duygun,ALKAN BAYLAN FİLİZ,Doğaner Adem,Orak Yavuz Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein. Turkish Journal of Medical Sciences, vol.50, no.4, 2020, ss.999 - 1006. 10.3906/sag-2002-53
AMA	KIRISCI M,Koçarslan A,Altıntaş Aykan D,ALKAN BAYLAN F,Doğaner A,Orak Y Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein. Turkish Journal of Medical Sciences. 2020; 50(4): 999 - 1006. 10.3906/sag-2002-53
Vancouver	KIRISCI M,Koçarslan A,Altıntaş Aykan D,ALKAN BAYLAN F,Doğaner A,Orak Y Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein. Turkish Journal of Medical Sciences. 2020; 50(4): 999 - 1006. 10.3906/sag-2002-53
IEEE	KIRISCI M,Koçarslan A,Altıntaş Aykan D,ALKAN BAYLAN F,Doğaner A,Orak Y "Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein." Turkish Journal of Medical Sciences, 50, ss.999 - 1006, 2020. 10.3906/sag-2002-53
ISNAD	KIRISCI, MEHMET vd. "Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein". Turkish Journal of Medical Sciences 50/4 (2020), 999-1006. https://doi.org/10.3906/sag-2002-53